Hanahan DJ |
The continuing biochemical challenge of PAF and closely related lipid mediators. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131117
|
Snyder F et al. |
Biosynthesis of platelet-activating factor and enzyme inhibitors. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131118
|
Satoh K et al. |
Production of platelet-activating factor by brain microvascular endothelial cells. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131120
|
Ahmed A and Dearn S |
The role of platelet-activating factor and its receptor in endometrial receptivity. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131161
|
Korth RM |
Non-specific PAF binding to embryonal F9 cells and prostacyclin synthesis in human umbilical vein endothelial cells. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131162
|
Zimmerman GA et al. |
Platelet-activating factor (PAF): signalling and adhesion in cell-cell interactions. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131163
|
Yang HC et al. |
Characterization of plasmalogen-selective phospholipase A2 from bovine brain. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131165
|
Ferby I et al. |
PAF-induced MAPK activation is inhibited by wortmannin in neutrophils and macrophages. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131167
|
Kochanek PM et al. |
Platelet activating factor antagonists do not alter normal cerebral blood flow or cerebral oxygen consumption. |
1990 |
Adv. Exp. Med. Biol. |
pmid:2096640
|
Camussi G et al. |
Antiflammins inhibit synthesis of platelet-activating factor and intradermal inflammatory reactions. |
1990 |
Adv. Exp. Med. Biol. |
pmid:2096695
|
Elizarova EP |
Effects of taurine on calcium in platelets and their aggregation. |
1996 |
Adv. Exp. Med. Biol. |
pmid:8915398
|
Kurachi M et al. |
Suppression of bronchial response to platelet activating factor following taurine administration. |
1987 |
Adv. Exp. Med. Biol. |
pmid:3434419
|
Pirotzky E et al. |
Involvement of platelet-activating factor in renal processes. |
1989 |
Adv. Lipid Res. |
pmid:2698054
|
Holleran WM |
Lipid modulators of epidermal proliferation and differentiation. |
1991 |
Adv. Lipid Res. |
pmid:1763711
|
Summers JB and Albert DH |
Platelet activating factor antagonists. |
1995 |
Adv. Pharmacol. |
pmid:7748804
|
Koltai M et al. |
Platelet-activating factor antagonists: scientific background and possible clinical applications. |
1994 |
Adv. Pharmacol. |
pmid:8080821
|
Matsumoto M and Miwa M |
Platelet-activating factor-binding protein in human serum. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3004155
|
Terashita Z et al. |
Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3004156
|
Foegh ML et al. |
Leukotrienes, thromboxane, and platelet activating factor in organ transplantation. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2959038
|
Robertson DN and Smith GM |
Role of thromboxane A2, 5-hydroxytryptamine, and platelet activating factor in collagen-induced sudden death in rabbits. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2959049
|